Reply to: RAAS inhibitors in COVID-19: Not all are created equal!

被引：3
作者：
Goncalves, Jorge [1 ,2 ]
Santos, Catarina D. [1 ]
Fresco, Paula [1 ,2 ]
Fernandez-Llimos, Fernando [1 ,2 ]
机构：
[1] Univ Porto, Fac Farm, Lab Farmacol, Porto, Portugal
[2] Univ Porto, Fac Pharm, Mechanist Pharmacol & Pharmacotherapy Unit, UCIBIO i4HB, Porto, Portugal
来源：
REVISTA PORTUGUESA DE CARDIOLOGIA | 2023年 / 42卷 / 09期
关键词：
TELMISARTAN; REDUCE;
D O I：
10.1016/j.repc.2023.06.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 818
页数：2
相关论文
共 12 条
  • [1] Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
    Bernal, A. Jayk
    da Silva, M. M. Gomes
    Musungaie, D. B.
    Kovalchuk, E.
    Gonzalez, A.
    Delos Reyes, V
    Martin-Quiros, A.
    Caraco, Y.
    Williams-Diaz, A.
    Brown, M. L.
    Du, J.
    Pedley, A.
    Assaid, C.
    Strizki, J.
    Grobler, J. A.
    Shamsuddin, H. H.
    Tipping, R.
    Wan, H.
    Paschke, A.
    Butterton, J. R.
    Johnson, M. G.
    De Anda, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) : 509 - 520
  • [2] Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
    Goncalves, Jorge
    Santos, Catarina D.
    Fresco, Paula
    Fernandez-Llimos, Fernando
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (04) : 373 - 383
  • [3] ARA that laughs?
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    Ruelle, Yannick
    [J]. EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2023, (190): : 95 - 95
  • [4] Renin-Angiotensin Aldosterone System Inhipitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research
    Loader, Jordan
    Taylor, Frances C.
    Lampa, Erik
    Sundstrom, Johan
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (11):
  • [5] Meredith PA, 1999, AM J CARDIOL, V84, p7K
  • [6] Does Losartan reduce the severity of COVID-19 in hypertensive patients?
    Mirjalili, Mohammadreza
    Soodejani, Moslem Taheri
    Raadabadi, Mehdi
    Dehghani, Ali
    Salemi, Fateme
    [J]. BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [7] Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial
    Nouri-Vaskeh, Masoud
    Kalami, Niusha
    Zand, Ramin
    Soroureddin, Zahra
    Varshochi, Mojtaba
    Ansarin, Khalil
    Rezaee, Haleh
    Taghizadieh, Ali
    Sadeghi, Armin
    Ahangari Maleki, Masoud
    Esmailnajad, Azam
    Saleh, Parviz
    Haghdoost, Mehdi
    Maleki, Mehdi
    Sharifi, Akbar
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [8] ARCTIC: Assessment of haemodynamic response in patients with congestive heart failure to telmisartan: A multicentre dose-ranging study in Canada
    Parker, AB
    Azevedo, ER
    Baird, MG
    Smith, SJ
    Arnold, JMO
    Humen, DP
    Moe, GW
    Parker, JO
    Butt, RW
    Parker, JD
    [J]. AMERICAN HEART JOURNAL, 1999, 138 (05) : 843 - 848
  • [9] Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury A Randomized Clinical Trial
    Puskarich, Michael A.
    Ingraham, Nicholas E.
    Merck, Lisa H.
    Driver, Brian E.
    Wacker, David A.
    Black, Lauren Page
    Jones, Alan E.
    Fletcher, Courtney, V
    South, Andrew M.
    Murray, Thomas A.
    Lewandowski, Christopher
    Farhat, Joseph
    Benoit, Justin L.
    Biros, Michelle H.
    Cherabuddi, Kartik
    Chipman, Jeffrey G.
    Schacker, Timothy W.
    Guirgis, Faheem W.
    Voelker, Helen T.
    Koopmeiners, Joseph S.
    Tignanelli, Christopher J.
    [J]. JAMA NETWORK OPEN, 2022, 5 (03)
  • [10] Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19
    Rothlin, Rodolfo Pedro
    Vetulli, Hector Miguel
    Duarte, Mariano
    Pelorosso, Facundo German
    [J]. DRUG DEVELOPMENT RESEARCH, 2020, 81 (07) : 768 - 770
12